Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments ...
In June, Johnson & Johnson agreed to pay $700 million to settle an investigation by 42 states and Washington, D.C., into the marketing of talc-based products blamed for allegedly causing cancer.
A state judge in Oregon has overturned a $260 million verdict against Johnson & Johnson in a mesothelioma lawsuit. The judge ...
Johnson & Johnson was founded over 125 years ... when it manufactured the first mass-produced sanitary protection products. When Robert Wood died in 1910, his brother James Wood became president ...
Johnson & Johnson is regaining momentum with strong growth in its Innovative Medicine and MedTech segments, driven by new products and strategic acquisitions. The company’s robust financials ...
Johnson Controls (NYSE: JCI), the global leader for smart, healthy and sustainable buildings, is showcasing its industry ...
Daratumumab is under clinical development by Johnson & Johnson and currently in Phase II for Antiphospholipid Syndrome.
In a report released today, Joanne Wuensch from Citi reiterated a Buy rating on Johnson & Johnson (JNJ – Research Report). The ...
The pro dancer also previews her partnership with Joey Graziadei, saying the Bachelor is 'humble and hardworking.' ...